The headlines have been running for years. Sperm counts are collapsing. Men are becoming infertile. The human species is in reproductive crisis. RFK Jr. cited it in speeches. Scientists have written open letters to governments about it. The 2017 meta-analysis that started the modern conversation has been cited thousands of times.
The reality, as of 2026, is more complicated than the headlines suggest — and more useful for any man who actually wants to understand what the research says about his own fertility.
This is what the science shows, where the genuine uncertainties are, and why the question of what is happening to sperm counts globally is separate from the question of what is happening to yours specifically.
What the Major Studies Actually Found
The conversation about declining sperm counts effectively began in 1992, when a large systematic review found that average sperm concentrations had dropped from around 113 million per milliliter in studies from the 1940s to around 66 million per milliliter by 1990. That paper was critiqued heavily, reanalyzed, and the overall conclusion held.
The modern version of the debate is anchored by two large meta-analyses from Dr. Hagai Levine and colleagues at the Hebrew University of Jerusalem. The 2017 study compiled data from 185 studies involving 42,935 men between 1973 and 2011. The 2023 update expanded that to 223 studies from 53 countries, covering data through 2018.
The findings from the 2023 analysis are stark. Across all continents, average sperm concentration fell by approximately 51.6% between 1973 and 2018, from around 101 million per milliliter to around 49 million per milliliter. Total sperm count declined by 62.3% over the same period among men not selected for fertility status. The rate of decline was not slowing. Post-2000 data showed the decline accelerating, with the annual rate of loss roughly doubling compared to the full period. (Levine et al., Human Reproduction Update, 2023)
These are significant numbers. But they require context before anyone draws conclusions about their own fertility.
Why the US Picture Looks Different
A 2025 meta-analysis from the Cleveland Clinic, led by Dr. Kieran Lewis and published in Fertility and Sterility, looked specifically at American men rather than global populations. It reviewed studies published between 1970 and 2023 and focused on fertile men and men without known infertility in the United States.
The conclusion was different from Levine's global findings. Among US men, sperm concentration showed no clinically significant change over the study period. In 49 study populations with adequate data, total sperm count actually increased by 2.9 million per year between 1970 and 2018. Subgroup analyses by US region and fertility status found no consistent declining trend. (Lewis et al., Fertility and Sterility, 2025)
This does not mean sperm counts in the US are fine and the global concern is overblown. It means the picture is geographically variable, that the populations included in studies matter enormously, and that a global average obscures very different regional realities. The Lewis analysis was restricted to men without known infertility, which is a meaningfully different population from the general male public.
What both sets of studies agree on is that population-level sperm concentration in 2026 is still above the WHO 6th Edition threshold of 16 million per milliliter for the average man. The concern is not that most men now fall below clinical thresholds. It is that the distribution has shifted, meaning more men fall into lower ranges than before, and that the long-term trajectory is worth taking seriously.
What Is Driving the Decline
The causes are not fully established. The research points to several contributing factors, none of which has been proven conclusively to be the primary driver, and most of which are likely acting together.
Endocrine-disrupting chemicals are the most researched candidate. Compounds like BPA (found in certain plastics and food packaging) and phthalates (found in plastics and many personal care products) can interfere with the hormonal signals that control sperm production. BPA appears to reduce LH secretion from the pituitary, lowering the hormonal signal that tells the testes to produce testosterone, which is essential for making sperm. Phthalates inhibit the enzymes involved in testosterone synthesis directly. Animal studies consistently show these effects. Human epidemiological data is more mixed, but the association between higher chemical exposure and worse semen parameters appears across multiple studies. (PMC, 2025)
Microplastics have moved from theoretical concern to documented presence. A 2024 study by researchers at the University of New Mexico found microplastics in every human testicular tissue sample they examined. A 2025 study published in International Urology and Nephrology found significantly higher microplastic concentrations in the semen of men with varicocele compared to fertile controls, and found that men with the highest plastic concentrations in their semen showed average sperm motility of around 21%, compared to 35% in men without detectable plastic. This is not a trivial difference in fertility terms.
How microplastics affect sperm is still being worked out. The proposed mechanisms include oxidative stress in testicular tissue, disruption of the blood-testis barrier, and interference with the hormone synthesis pathways described above. The research is still early-stage in humans, and causal relationships have not been established. But the ubiquity of plastic exposure, combined with what is being found in human reproductive tissue, makes this an area the field is taking seriously.
Lifestyle factors are well-established contributors at the individual level, even if their contribution to population-level trends is harder to quantify. Obesity reduces sperm production through a specific mechanism: fat tissue contains an enzyme called aromatase that converts testosterone into estrogen. The more body fat a man carries, the more testosterone gets converted, which lowers the hormonal signal to the testes and reduces sperm output. Smoking is directly associated with elevated DNA fragmentation, lower sperm concentration, and worse motility. Poor sleep, chronic stress, and sedentary behavior are all associated with lower testosterone and worse semen parameters in the research literature.
What the 50% Decline Actually Means for Fertility
The most important thing to understand about the population-level decline is what it does and does not imply for any individual man.
Average sperm concentration falling from ~101 million/mL in 1973 to ~49 million/mL in 2018 is a large shift in population averages. But 49 million/mL is still well above the WHO 6th Edition clinical threshold of 16 million/mL. The concern is not that the average man in 2026 is infertile by clinical definition. It is that more men now cluster in the ranges between 16 and 40 million/mL than did 50 years ago, ranges where fertility is possible but conception may take longer, where other parameters like motility and DNA fragmentation become more important, and where subfertility rather than infertility becomes the relevant concept.
Subfertility is not infertility. It is not a clinical diagnosis. But it matters for time-to-pregnancy, for the likelihood that a couple will need medical assistance, and for outcomes in IVF and ICSI where sperm quality plays a real role.
This is the context in which measuring your own numbers matters. Population trends tell you the direction the average is moving. They do not tell you where you sit in that distribution.
Why Knowing Your Numbers Is the Relevant Question
Here is the practical implication of all of this research for a man in 2026.
The evidence for a real, sustained population-level decline in sperm counts is substantial, even if the exact magnitude is debated and the US picture looks different from global data. The causes are likely environmental, chemical, and lifestyle-related, acting across decades. None of this is reversible at the population level by individual action.
What is within an individual man's control is understanding where his numbers sit, whether any modifiable factors are contributing to his specific situation, and whether there is anything to address before it becomes a clinical problem.
Most men who get a semen analysis done are doing it because something is already wrong, or because they have been trying to conceive without success. The population-level trends suggest there is a reasonable case for testing earlier, before conception becomes the focus, in the same way that men in their thirties do not wait for cardiovascular symptoms before getting cholesterol checked.
DNA fragmentation is the parameter most consistently underexplored in this context. Standard semen analysis does not include it. Yet oxidative stress, which is driven by many of the same environmental and lifestyle exposures being discussed in the decline research, is the primary mechanism through which DNA fragmentation rises. A man with normal concentration and motility but elevated DNA fragmentation may have normal-looking numbers and still face reduced fertility.
The question the research in 2026 points toward is not "are sperm counts declining globally" — the evidence says, broadly, yes, though with real geographic variation. The question is: what does that mean for the decisions available to you right now?
Testing is what converts a population trend into personal information. The rest is data.
Our Take
The sperm count decline story is real in the sense that the population-level data is consistent, has been replicated across multiple large meta-analyses, and points to a genuine long-term shift. It is incomplete in the sense that geographic variation is significant, the US picture is more stable than the global average, the causes are not fully established, and most men in 2026 are not clinically infertile by WHO thresholds.
What we are confident about: sperm quality is measurable, modifiable factors exist, and the earlier a man knows his numbers the more options he has. The population-level decline is not a reason for fatalism. It is a reason for data.
The conversation in 2026 has moved from "is this happening" to "what are the mechanisms and what can be done." That is the right frame. And it starts with measurement.
SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.
